Janney Montgomery Scott
PTCT icon

Janney Montgomery Scott’s PTC Therapeutics PTCT Stock Holding History

Janney Montgomery Scott’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
4,513
-867
-16% -$62.6K ﹤0.01% 2599
2026
Q1 		$367K Sell
5,380
-303
-5% -$21.5K ﹤0.01% 2253
2025
Q4 		$432K Hold
5,683
– – ﹤0.01% 2302
2025
Q3 		$349K Sell
5,683
-245
-4% -$12.8K ﹤0.01% 2396
2025
Q2 		$290K Hold
5,928
– – ﹤0.01% 2347
2025
Q1 		$302K Sell
5,928
-37
-0.6% -$1.85K ﹤0.01% 2301
2024
Q4 		$269K Buy
5,965
+455
+8% +$19.5K ﹤0.01% 2378
2024
Q3 		$204K Buy
+5,510
New +$184K ﹤0.01% 2503
2018
Q1 		– Sell
-26,927
Closed -$449K – 1988
2017
Q4 		$449K Sell
26,927
-900
-3% -$15.2K ﹤0.01% 1366
2017
Q3 		$557K Sell
27,827
-5,458
-16% -$107K 0.01% 1206
2017
Q2 		$610K Buy
33,285
+16,685
+101% +$225K 0.01% 1094
2017
Q1 		$163K Buy
+16,600
New +$201K ﹤0.01% 1649

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Janney Montgomery Scott's PTCT Position: Q2 2026 in Review

Janney Montgomery Scott reduced its PTC Therapeutics (PTCT) stake by 16% in Q2 2026, selling an estimated $62.6K and leaving 4,513 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Janney Montgomery Scott first reported a position in PTCT in Q1 2017 and has held it in 12 quarters since. The position peaked at $610K in Q2 2017. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Janney Montgomery Scott held 4,513 shares of PTC Therapeutics worth $368K as of Q2 2026.
  • Janney Montgomery Scott sold 867 PTC Therapeutics shares in Q2 2026, an estimated $62.6K.
  • PTC Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2599 holding.
  • Janney Montgomery Scott first reported a position in PTC Therapeutics in Q1 2017 and has held it in 12 quarters since.
  • Janney Montgomery Scott's PTC Therapeutics position peaked at $610K in Q2 2017.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.